Psychosocial predictors of mortality following lung transplantation

American Journal of Transplantation

Volumn 16, Issue 1, 2016, Pages 271-277

  Smith, P J ^a   Blumenthal, J A ^a   Trulock, E P ^b   Freedland, K E ^b   Carney, R M ^b   Davis, R D ^a   Hoffman, B M ^a   Palmer, S M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT;

ADULT; AFFECT; ANXIETY ASSESSMENT; ARTICLE; BECK DEPRESSION INVENTORY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE THERAPY; CONTROLLED STUDY; DEPRESSION; DISTRESS SYNDROME; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; FORCED EXPIRATORY VOLUME; GENERAL HEALTH QUESTIONNAIRE; GRAFT RECIPIENT; HUMAN; LONG TERM SURVIVAL; LUNG FIBROSIS; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); NEGATIVE AFFECT; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOCIAL PSYCHOLOGY; SPIELBERGER ANXIETY INVENTORY; STATE TRAIT ANXIETY INVENTORY; SURGICAL MORTALITY; ADVERSE EFFECTS; ANXIETY; DEPRESSIVE DISORDER, MAJOR; GRAFT REJECTION; GRAFT SURVIVAL; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATION; PROGNOSIS; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ANXIETY; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK FACTORS; TRANSPLANT RECIPIENTS;

EID: 84956911992     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13447     Document Type: Article

References (44)

1. Parekh PI, Blumenthal JA, Babyak MA, et al., Psychiatric disorder and quality of life in patients awaiting lung transplantation. Chest 2003; 124: 1682-1688.
2. Limbos MM, Joyce DP, Chan CK, Kesten S., Psychological functioning and quality of life in lung transplant candidates and recipients. Chest 2000; 118: 408-416.
3. Evon DM, Burker EJ, Galanko JA, Dedert E, Egan TM., Depressive symptoms and mortality in lung transplant. Clin Transplant 2010; 24: E201-E206.
4. Chacko RC, Harper RG, Gotto J, Young J., Psychiatric interview and psychometric predictors of cardiac transplant survival. Am J Psychiatry 1996; 153: 1607-1612.
5. Rosenberger EM, Dew MA, Crone C, DiMartini AF., Psychiatric disorders as risk factors for adverse medical outcomes after solid organ transplantation. Curr Opinion Organ Transplant 2012; 17: 188-192.
6. Barth J, Schumacher M, Herrmann-Lingen C., Depression as a risk factor for mortality in patients with coronary heart disease: A meta-analysis. Psychosom Med 2004; 66: 802-813.
7. Blumenthal JA, Lett H, Babyak M, et al., Depression as a risk factor for mortality following coronary artery bypass surgery. Lancet 2003; 362: 604-609.
8. Connerney I, Shapiro PA, McLaughlin JS, Bagiella E, Sloan RP., Relation between depression after coronary artery bypass surgery and 12-month outcome: A prospective study. Lancet 2001; 358: 1766-1771.
9. Connerney I, Sloan RP, Shapiro PA, Bagiella E, Seckman C., Depression is associated with increased mortality 10 years after coronary artery bypass surgery. Psychosom Med 2010; 72: 874-881.
10. Smith PJ, Blumenthal JA, Carney RM, et al., Neurobehavioral functioning and survival following lung transplantation. Chest 2014; 145: 604-611.
11. Dew MA, DiMartini AF, DeVito Dabbs AJ, et al., Onset and risk factors for anxiety and depression during the first 2 years after lung transplantation. Gen Hosp Psychiatry 2012; 34: 127-138.
12. Barbour KA, Blumenthal JA, Palmer SM., Psychosocial issues in the assessment and management of patients undergoing lung transplantation. Chest 2006; 129: 1367-1374.
13. Dobbels F, Vanhaecke J, Dupont L, et al., Pretransplant predictors of posttransplant adherence and clinical outcome: An evidence base for pretransplant psychosocial screening. Transplantation 2009; 87: 1497-1504.
14. Denhaerynck K, Steiger J, Bock A, et al., Prevalence and risk factors of non-adherence with immunosuppressive medication in kidney transplant patients. Am J Transplant 2007; 7: 108-116.
15. De Geest S, Dobbels F, Fluri C, Paris W, Troosters T., Adherence to the therapeutic regimen in heart, lung, and heart-lung transplant recipients. J Cardiovasc Nurs 2005; 20 (Suppl): S88-S98.
16. Wainwright SP, Gould D., Non-adherence with medications in organ transplant patients: A literature review. J Adv Nurs 1997; 26: 968-977.
17. Butler JA, Roderick P, Mullee M, Mason JC, Peveler RC., Frequency and impact of nonadherence to immunosuppressants after renal transplantation: A systematic review. Transplantation 2004; 77: 769-776.
18. Stilley CS, Dew MA, Stukas AA, et al., Psychological symptom levels and their correlates in lung and heart-lung transplant recipients. Psychosomatics 1999; 40: 503-509.
19. Blumenthal JA, Babyak MA, Keefe FJ, et al., Telephone-based coping skills training for patients awaiting lung transplantation. J Consult Clin Psychol 2006; 74: 535-544.
20. Beck AT, Steer RA, Brown GK., Beck Depression Inventory manual. San Antonio, TX: The Psychological Corporation; 1996.
21. Spielberger CE, Gorsuch RL., Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1970.
22. Goldberg D., The detection of psychiatric illness by questionnaire. London: Oxford University Press; 1972.
23. Blumenthal JA, Burg MM, Barefoot J, Williams RB, Haney T, Zimet G., Social support, type A behavior, and coronary artery disease. Psychosom Med 1987; 49: 331-340.
24. Egan TM, Murray S, Bustami RT, et al., Development of the new lung allocation system in the United States. Am J Transplant 2006; 6: 1212-1227.
25. O'Brien PC., Procedures for comparing samples with multiple endpoints. Biometrics 1984; 40: 1079-1087.
26. Squier HC, Ries AL, Kaplan RM, et al., Quality of well-being predicts survival in lung transplantation candidates. Am J Resp Crit Care 1995; 152: 2032-2036.
27. Zipfel S, Schneider A, Wild B, et al., Effect of depressive symptoms on survival after heart transplantation. Psychosom Med 2002; 64: 740-747.
28. Rogal SS, Dew MA, Fontes P, DiMartini AF., Early treatment of depressive symptoms and long-term survival after liver transplantation. Am J Transplant 2013; 13: 928-935.
29. Dew MA, Kormos RL, Roth LH, Murali S, DiMartini A, Griffith BP., Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant 1999; 18: 549-562.
30. De Vito Dabbs A, Dew MA, Stilley CS, et al., Psychosocial vulnerability, physical symptoms and physical impairment after lung and heart-lung transplantation. J Heart Lung Transplant 2003; 22: 1268-1275.
31. Dew MA, DiMartini AF., Psychological disorders and distress after adult cardiothoracic transplantation. J Cardiovasc Nurs 2005; 20 (Suppl): S51-S66.
32. Copeland CA, Vock DM, Pieper K, Mark DB, Palmer SM., Impact of lung transplantation upon recipient quality of life: A serial, prospective, multi-center analysis through the first posttransplant year. Chest 2013; 143: 744-750.
33. Dew MA, Roth LH, Thompson ME, Kormos RL, Griffith BP., Medical compliance and its predictors in the first year after heart transplantation. J Heart Lung Transplant 1996; 15: 631-645.
34. Surman OS, Cosimi AB, DiMartini A., Psychiatric care of patients undergoing organ transplantation. Transplantation 2009; 87: 1753-1761.
35. Jowsey SG, Taylor ML, Schneekloth TD, Clark MM., Psychosocial challenges in transplantation. J Psychiatr Pract 2001; 7: 404-414.
36. Denhaerynck K, Burkhalter F, Schafer-Keller P, Steiger J, Bock A, De Geest S., Clinical consequences of non adherence to immunosuppressive medication in kidney transplant patients. Transplant Int 2009; 22: 441-446.
37. Russell CL, Conn VS, Ashbaugh C, Madsen R, Hayes K, Ross G., Medication adherence patterns in adult renal transplant recipients. Res Nurs Health 2006; 29: 521-532.
38. Lichtman JH, Bigger JT Jr, Blumenthal JA, et al., Depression and coronary heart disease: Recommendations for screening, referral, and treatment: A science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Psychiatric Association. Circulation 2008; 118: 1768-1775.
39. Gorevski E, Succop P, Sachdeva J, et al., Is there an association between immunosuppressant therapy medication adherence and depression, quality of life, and personality traits in the kidney and liver transplant population? Patient Prefer Adherence 2013; 7: 301-307.
40. Hall DJ, Baz M, Daniels MJ, et al., Immediate postoperative inflammatory response predicts long-term outcome in lung-transplant recipients. Interactive Cardiovasc Thoracic Surg 2012; 15: 603-607.
41. de Jonge P, Rosmalen JG, Kema IP, et al., Psychophysiological biomarkers explaining the association between depression and prognosis in coronary artery patients: A critical review of the literature. Neurosci Biobehav Rev 2010; 35: 84-90.
42. Martinu T, Babyak MA, O'Connell CF, et al., Baseline 6-min walk distance predicts survival in lung transplant candidates. Am J Transplant 2008; 8: 1498-1505.
43. Blumenthal JA, Sherwood A, Babyak MA, et al., Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: Results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study. J Am Coll Cardiol 2012; 60: 1053-1063.
44. Milani RV, Lavie CJ, Mehra MR, Ventura HO,. Impact of exercise training and depression on survival in heart failure due to coronary heart disease. Am J Cardiol 2011; 107: 64-68.